APA (7th ed.) Citation

Liu, Y., Chang, T., Wang, Z., Liu, H., Li, F., Cui, C., . . . Zhang, S. (2025). Wenyang Jiedu Tongluo formula ameliorates diabetic kidney disease by regulating JAML/SIRT1 signaling to improve lipid metabolism in db/db mice. Frontiers in pharmacology, 16, 1611585. https://doi.org/10.3389/fphar.2025.1611585

Chicago Style (17th ed.) Citation

Liu, Yutong, Tianying Chang, Zikun Wang, Hongkai Liu, Fan Li, Chengji Cui, Yingzi Cui, and Shoulin Zhang. "Wenyang Jiedu Tongluo Formula Ameliorates Diabetic Kidney Disease by Regulating JAML/SIRT1 Signaling to Improve Lipid Metabolism in Db/db Mice." Frontiers in Pharmacology 16 (2025): 1611585. https://doi.org/10.3389/fphar.2025.1611585.

MLA (9th ed.) Citation

Liu, Yutong, et al. "Wenyang Jiedu Tongluo Formula Ameliorates Diabetic Kidney Disease by Regulating JAML/SIRT1 Signaling to Improve Lipid Metabolism in Db/db Mice." Frontiers in Pharmacology, vol. 16, 2025, p. 1611585, https://doi.org/10.3389/fphar.2025.1611585.